Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

SHA:603207 Revenue

Shanghai Xiao Fang Pharmaceutical had revenue of 127.43M CNY in the quarter ending September 30, 2025, with 20.87% growth. This brings the company's revenue in the last twelve months to 504.59M, up 6.89% year-over-year. In the year 2024, Shanghai Xiao Fang Pharmaceutical had annual revenue of 474.58M with 0.57% growth.

• Revenue (ttm): 504.59M
• Revenue Growth: +6.89%
• P/S Ratio: 9.60
• Revenue / Employee: 1.25M
• Employees: 404
• Market Cap: 4.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	474.58M	2.71M	0.57%
Dec 31, 2023	471.87M	14.98M	3.28%
Dec 31, 2022	456.89M	55.12M	13.72%
Dec 31, 2021	401.77M	40.54M	11.22%
Dec 31, 2020	361.23M	21.62M	6.37%